Login / Signup

Fisetin alleviates chronic urticaria by inhibiting mast cell activation via MRGPRX2.

Yonghui ZhangYihan HuangBaowen DangShiting HuChenrui ZhaoYuejin WangYujuan YuanRui Liu
Published in: The Journal of pharmacy and pharmacology (2023)
Fisetin alleviates CU progression by inhibiting mast cell activation via MRGPRX2, which may be a novel therapeutic candidate for CU.
Keyphrases
  • signaling pathway
  • mouse model
  • aqueous solution
  • metal organic framework
  • drug induced